The Scientific Research and Development team at Passage Bio is responsible for spearheading innovative research and development efforts in the field of gene therapy. This team collaborates on designing and conducting experiments, developing AAV-based therapeutics, and optimizing processes to ensure their efficacy for treating rare monogenic CNS disorders. They also focus on biomarker identification and validation to support clinical development, leveraging their expertise to advance the company's therapeutic pipeline.
View all